Oscar Wilde once wrote, “Life imitates art far more than art imitates life.” My experience with cancer treatment mirrors Pixar’s parody of how insurance works in The Incredibles. And listen—whether or not you see The…
Continue Reading
Chelsea and Westminster patients have been part of new research that has determined that the majority would rather have their skin assessed by artificial intelligence than wait weeks to see a dermatologist in person.The…
Continue Reading
By Shania Kennedy
December 05, 2023 – A deep learning model can accurately identify non-smokers at high risk for lung cancer using only routine chest X-rays, according to research presented at this year’s meeting of the…
Continue Reading
Fred Hutchinson Cancer Center faced a breach during Thanksgiving, impacting patient and employee data. An external criminal group infiltrated their clinical network, posing uncertainties about compromised information. The breach didn’t affect Epic health records,…
Continue Reading
The Fred Hutchinson Cancer Center, an independent organization also serving as the cancer program for the University of Washington School of Medicine, said Friday that it was still assessing the potential impact on patients and employees.WHY…
Continue Reading
To resolve these problems, Yakima Memorial turned to a Verkada hybrid cloud system incorporating advanced AI across seven physical locations. Additional sites, such as the North Star Lodge Cancer Care Center and Children’s Village,…
Continue Reading
What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
– This…
Continue Reading
Americans can’t afford their medications. About 25% leave prescriptions unfilled, split pills, or skip doses. Seniors face challenges covering non-Medicare services, including prescriptions. Even those with commercial health insurance are not immune. One-third of…
Continue Reading
What You Should Know:
– Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has partnered with NTT DATA Singapore to introduce Lunit INSIGHT CXR at Singapore General Hospital (SGH) and Changi General…
Continue Reading
Collaborating for biologic breakthroughs, IBM and Boehringer Ingelheim merge genAI with foundation models. IBM’s cutting-edge AI expedites antibody discovery, targeting diseases like cancer, autoimmune disorders, and infections. Boehringer’s validation of refined antibodies affirms in-silico…
Continue Reading
